1.
Recasting Asilomar's lessons for human germline editing
by Miller, Henry I
Nature biotechnology, 2015-11, Vol.33 (11), p.1132-1134
2.
US Congress mandates silliness, USDA complies
by Miller, Henry I
Nature biotechnology, 2019-05, Vol.37 (5), p.497-498
3.
Basic research is often best appreciated in retrospect
by Miller, Henry I
Nature biotechnology, 2014-01, Vol.32 (1), p.24-25
4.
FDA is the wrong agency to regulate genetically engineered animals
by Cohrssen, John J
Nature biotechnology, 2017-07-12, Vol.35 (7), p.620-622
5.
Personalized Medicine Needs Enlightened Regulation to Realize its Potential
by Miller, Henry I
Journal of commercial biotechnology, 2017-10-01, Vol.23 (4), p.3
6.
Why an abbreviated FDA pathway for biosimilars is overhyped
by Miller, Henry I
Nature biotechnology, 2011-09-08, Vol.29 (9), p.794-795
7.
Biotechnology can Address the Mystery and Urgency of Alzheimer's Disease
by Marmor, Mina
Journal of commercial biotechnology, 2017-10-01, Vol.23 (4), p.8
8.
Split approvals and hot potatoes
by Miller, Henry I
Nature biotechnology, 2010-06, Vol.28 (6), p.552-553
9.
Agricultural Biotechnology Is Much More Than Herbicide-Tolerant Crops
by Miller, Henry I.
Journal of commercial biotechnology, 2017-01-01, Vol.23 (1), p.7
10.
Why FDA recruitment of 'critics' is a problem
by Miller, Henry I
Nature biotechnology, 2010-03, Vol.28 (3), p.212-212
11.
Auf Wiedersehen , agbiotech
by Miller, Henry I
Nature biotechnology, 2008-09, Vol.26 (9), p.974-975
12.
A label we don't need
by Miller, Henry I
Nature biotechnology, 2011-11-08, Vol.29 (11), p.971-972
13.
Biogenerics: the hope and the hype
by Miller, Henry I
Trends in biotechnology (Regular ed.), 2009, Vol.27 (8), p.443-444
14.
A ‘Genetically Engineered’ Label: Way More Expensive Than You Think
by Miller, Henry I
Journal of commercial biotechnology, 2015-07-01, Vol.21 (3), p.13
15.
FDA on transgenic animals-a dog's breakfast?
by Miller, Henry I
Nature biotechnology, 2008-02, Vol.26 (2), p.159-160
16.
A golden opportunity, squandered
by Miller, Henry I
Trends in biotechnology (Regular ed.), 2009, Vol.27 (3), p.129-130
17.
Investing in bad science.(wasteful government spending and research funding)
by Miller, Henry I
Policy review (Washington, D.C.), 2013-02-01 (177), p.33-42
18.
Is biotechnology a victim of anti-science bias in scientific journals?
by Miller, Henry I
Trends in biotechnology (Regular ed.), 2008, Vol.26 (3), p.122-125
19.
Genetically engineered wheat, redux
by Miller, Henry I
Trends in biotechnology (Regular ed.), 2009, Vol.28 (1), p.1-2
20.
Two views of the emperor's new clones
by Miller, Henry I
Nature biotechnology, 2007-03, Vol.25 (3), p.281-281
